How quickly Wegovy works — and why the first few weeks aren't the whole story

The biggest myth: that Wegovy should be working dramatically by week two

Most people who contact their pharmacy worried that Wegovy "isn't working" are still on the 0.25 mg starting dose. That dose exists to let your system settle, nausea is common early on, and a lower starting dose reduces it. The medicine's job at 0.25 mg is adjustment, not aggressive appetite suppression. Expecting significant weight loss at this stage is like expecting a car to be at motorway speed the moment you pull out of a parking space.

The titration schedule moves through 0.5 mg, 1.0 mg, 1.7 mg and eventually 2.4 mg, with roughly four weeks at each level. Most people reach 2.4 mg (the standard maintenance dose) around month four or five. Weight loss tends to accelerate once you're at or approaching that level, which means the treatment's real performance window is months four through sixteen, not weeks one through four.

Appetite reduction, on the other hand, does arrive earlier. Many people notice they feel full sooner at meals within the first week or two. That subjective signal is real and worth paying attention to, it is how the medicine starts working before the scales shift. The full Wegovy overview explains the mechanism behind this in more detail.

What the STEP 1 trial data tells us about the actual pace of loss

The STEP 1 trial (published in the New England Journal of Medicine) randomised over 1,900 adults with obesity or overweight and at least one weight-related condition to either semaglutide 2.4 mg or placebo, alongside lifestyle support, over 68 weeks. Average weight reduction in the treatment group was around 15% of body weight.

What the headline figure doesn't show is the shape of the curve. Loss is not linear. The steepest drop tends to occur between roughly weeks eight and thirty-two, once people have reached or are approaching full dosing. Progress slows after that as the body adjusts, before reaching a new, lower plateau. Some participants continued losing weight beyond week 52. Others plateaued earlier. Genetics, starting BMI, adherence to diet changes and physical activity all influence where on that curve any individual sits.

If you're curious about how quickly weight loss typically happens on Wegovy week by week, the short version is: slower at first, faster in the middle months, then a natural levelling. That levelling is not failure, it is physiology.

What can slow or speed Wegovy's effects for you personally

Several things influence how quickly Wegovy will work for you, but dose stage is the biggest factor, for reasons covered above. Diet matters too: semaglutide reduces appetite but doesn't override energy balance entirely, and people who adjust their eating habits alongside treatment tend to see results arrive faster. Adequate protein and fibre help maintain the satiety signals the medicine is amplifying.

Sleep, stress levels, and how consistently you inject on the same day each week also play a role. The injection routine itself is straightforward, many people keep their pen in the fridge door alongside everyday items and inject on a fixed morning each week, which helps with consistency. Missing doses, or injecting at irregular intervals, can blunt the medicine's steadiness.

Side effects, particularly gastrointestinal ones (nausea, loose stools, reduced appetite to the point of not eating enough), can also affect early progress in both directions. Nausea may suppress appetite more than the medicine alone, and if you want a clearer picture of how quickly Wegovy works for weight loss once side effects settle, the answer is that meaningful change typically becomes visible from around month two onwards. If side effects are severe enough to disrupt eating or cause dehydration, they need clinical attention. Report anything that concerns you to your prescriber promptly. You can also report suspected side effects directly via the MHRA's Yellow Card scheme.

Cost is occasionally a reason people delay moving through the dose schedule, taking fewer pens to stretch their supply. That approach is clinically inadvisable and slows results. A clear picture of Wegovy pricing in the UK helps with planning from the start.

When to raise a concern with your prescriber

NICE guidance on semaglutide recommends reviewing whether to continue if less than 5% weight loss has been achieved after six months at the maintenance dose, so persistence through the titration phase matters, and six months is the benchmark, not six weeks. See the NICE technology appraisal for Wegovy (TA875) for the published criteria.

If you reach the maintenance dose and see genuinely no response over several months, that is worth a frank conversation with your prescriber. It does not happen often, but some people respond less well to semaglutide than others, the dual-agonist mechanism in tirzepatide works differently, and for some it produces a stronger response. Your prescriber can discuss whether an alternative is appropriate. If you have questions about the process at any stage, our FAQs cover many common concerns, or you can reach the team directly through our contact page.

For most people, the right response to "it's not working yet" in the first month is: keep going, stay consistent, and give the titration schedule time to do its job. Speak to our prescribers if you want clinical guidance tailored to where you actually are in the process.